Performance analysis of Ocuphire Pharma (IRD)
Annual Return
Over the past 3 years, IRD has had an average annual return of -9.16%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, IRD has had an average annual return of -7.50%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, IRD has had an average annual return of -31.05%, underperforming the benchmark SPY, which returned +15.04% annual.
Since May 23, 2005, IRD has had an average annual return of -25.26%, underperforming the benchmark SPY, which returned +11.07% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +50% | +75% | -61.90% | -16.00% | -3.85% | -42.22% | -15.09% | -82.90% | -53.94% | +42.28% | -60.91% | -48.14% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | ||
| +37.24% | +64.57% | -17.56% | -66.43% | +64.67% | -23.59% | -60.42% | +66.60% | -32.50% | -33.33% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +14.29% | +81.25% | +10.34% | +9.38% | -14.29% | -3.33% | -27.59% | +50% | |||||
| 2025 | +0% | -12.50% | +0% | +0% | +0% | +0% | +14.29% | +0% | +37.50% | +45.45% | -6.25% | -6.67% | +75% |
| 2024 | -14.29% | +0% | -22.22% | -21.43% | +9.09% | -8.33% | +27.27% | -35.71% | +0% | -11.11% | +0% | +0% | -61.90% |
| 2023 | -4.00% | -0% | +8.33% | +38.46% | -25.00% | +11.11% | -0% | -6.67% | -17.86% | -13.04% | +5% | -0% | -16.00% |
| 2022 | -15.38% | +9.09% | -4.17% | -30.43% | -6.25% | -13.33% | -0% | +23.08% | -12.50% | +14.29% | +31.25% | +19.05% | -3.85% |
| 2021 | +80% | -8.64% | -45.95% | -12.50% | -8.57% | +15.62% | -21.62% | +6.90% | +16.13% | -25.00% | -0% | -3.70% | -42.22% |
| 2020 | +7.55% | +14.04% | -23.08% | +6% | +32.08% | +12.86% | -6.33% | -14.86% | -7.94% | +3.45% | -28.33% | +4.65% | -15.09% |
| 2019 | -31.29% | -18.78% | -1.73% | -2.94% | -16.97% | +4.38% | -0.70% | -57.04% | -6.56% | -17.54% | +2.13% | +10.42% | -82.90% |
| 2018 | +3.57% | -23.53% | -5.63% | +15.31% | +28.79% | -37.08% | +7.02% | +13.92% | +3.49% | -35.41% | -6.01% | -13.89% | -53.94% |
| 2017 | +21.35% | +44.60% | +104.82% | -15.65% | -11.65% | -24.78% | -26.23% | +14.22% | +0.50% | -27.26% | +22.15% | -6.14% | +42.28% |
Drawdown analysis of Ocuphire Pharma (IRD)
The maximum drawdown for the IRD was -99.98%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current IRD drawdown is -99.89%.
Since May 23, 2005 IRD has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | May 27, 2008 | 4243 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -78.00% | Aug 29, 2006 | 82 | Dec 26, 2006 | 355 | May 27, 2008 | 437 |
| -75.00% | Aug 25, 2005 | 210 | Jun 27, 2006 | 44 | Aug 29, 2006 | 254 |
| -23.08% | Jun 22, 2005 | 15 | Jul 14, 2005 | 9 | Jul 27, 2005 | 24 |
| -16.67% | May 23, 2005 | 3 | May 26, 2005 | 18 | Jun 22, 2005 | 21 |